SQZ-AAC-HPV

N/A

Report date: 2024/07/26 20:00:47
First In Class

Base Information

Drug NameSQZ-AAC-HPV
Drug Alias NameN/A
ClassificationVaccines
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsSolid tumoursUterine Cervical NeoplasmsHead and Neck Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesSqz Biotechnologies Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLonza Biologics IncSqz Biotechnologies CompanyBeijing Kendlewits Medical Consulting Co Ltd
Active IndicationsN/A
Inactive IndicationsSolid tumoursUterine Cervical NeoplasmsHead and Neck Neoplasms +[4] 

Other Information

ATC CodeN/A
Related LinksN/A